PUBLISHER: Grand View Research | PRODUCT CODE: 2132362
PUBLISHER: Grand View Research | PRODUCT CODE: 2132362
The global skin substitutes market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 4.9 billion by 2033, at a CAGR of 11.7% from 2026 to 2033. North America dominated the skin substitutes market with the largest revenue share of 41.3% in 2025. The growth of the global skin substitutes market is driven by the rising prevalence of chronic wounds, diabetic foot ulcers, burns, and pressure ulcers worldwide.
Increasing adoption of advanced wound care solutions, growing geriatric populations, and rising healthcare expenditure are driving demand for regenerative therapies.
The rising prevalence of diabetes and its associated complications, particularly diabetic foot ulcers (DFUs), is a major driver for the growth of the skin substitutes market. Diabetes impairs wound healing due to reduced blood circulation, neuropathy, and increased risk of infections, leading to a higher demand for advanced wound care solutions. The increasing number of diabetic patients across U.S. states and globally is expanding the patient pool requiring regenerative therapies, including biological and synthetic skin substitutes, to accelerate tissue repair and reduce amputation risks.
Global Skin Substitutes Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global skin substitutes market report based on product, application, end use, and region: